jeonbuk national university

Wits Health Consortium

Wits Health Consortium (Pty) Limited (“WHC“) is a wholly owned Company of the University of the Witwatersrand, Johannesburg (South Africa) under its Faculty of Health Sciences. WHC provides Faculty with a legal framework within which to operate the research and other activities necessary to support its academic objectives. In addition WHC offers a range of products and services to the Academics conducting these activities in order to assist with the management thereof. WHC was formed in March 1998 to harness and stimulate the commercial potential within Faculty, and in particular to capitalise on clinical research. The flexible manner in which WHC is structured encourages academics to operate their entities along entrepreneurial lines with strong investigator ownership. WHC balances reducing unnecessary bureaucratic control whilst still ensuring that activities are conducted in a formalised, controlled and well managed environment. WHC has also been the fertile breeding ground for many initiatives, the most notable being the formation of the Wits Donald Gordon Medical Centre which was incubated within WHC and eventually established in its own entity. WHC is a not-for-profit organisation as all surpluses are reinvested in either WHC's or the University's operational and academic infrastructures.

The National Research Foundation of South Africa (NRF)

The National Research Foundation (NRF) was established as an independent government agency, through the National Research Foundation Act (Act No 23 of 1998). The mandate of the NRF is to promote and support research through funding, human resource development and the provision of the necessary research facilities in order to facilitate the creation of knowledge, innovation and development in all fields of science and technology, including indigenous knowledge, and thereby contribute to the improvement of the quality of life of all South Africans.

Council for Scientific and Industrial Research (CSIR)

CSIR vision We are accelerators of socio-economic prosperity in South Africa through leading innovation CSIR mission Collaboratively innovating and localising technologies while providing knowledge solutions for the inclusive and sustainable advancement of industry and society CSIR values Our beliefs, principles and the impact we wish to make to improve the quality of life of South Africans are EPIC. Team CSIR pursues Excellence, celebrates People, personifies Integrity, and welcomes Collaboration.

Seegene Inc.

[INTRODUCING OUR COMPANY] The people of Seegene are on a purposeful mission to improve the world we live in. We aim to improve the quality of life for everyone globally by bringing molecular diagnostics to the masses. Molecular diagnostics is the most effective method to accurately diagnose ailments and is also the best way to diagnose them early which is when you can make the most difference in the recovery treatment. With industry-leading IP in molecular diagnostics reagent assays, we are dedicated to leveraging our unique technologies to increase our product portfolio, expand our market coverage, and lowering the total cost to serve our customers so that molecular diagnostics become a part of the fabric of everyone’s life and thus, improving the quality of life for everyone in the world. [OUR HISTORY AND OUR FUTURE] Since our founding in 2000, we have been steadfastly focused on molecular diagnostics. Currently, our product portfolio consists of over 250 molecular diagnostics reagent kits as well as a wide range of instruments and consumables that are sold globally. Testament to our expertise, when the pandemic started, Seegene was one of the first companies in the world to provide testing kits that were crucial in the fight against COVID. Today, we are a company with revenue of over $1 billion dollars and 65% gross margins. With 8 overseas entities, we generate a majority of our revenue outside of Korea. In keeping with our spirit of innovation and making a difference in the world, there are many exciting innovations being worked on at Seegene which will make it easier for the world to access the benefits of molecular diagnostics. We are transforming our business from a discrete reagent assay and instruments business to a platform business that will create new markets for molecular diagnostics and improve the quality of life for everyone. We hope that you will join us in our mission to make a meaningful difference in the world.